▟ Vinebot intrinsic value, daily

← back

IFF International Flavors & Fragrances

materials · valued with opus low conviction · deep-dived 2026-11-17

SELL
Intrinsic value$28.82
Price (at call)$79.99
Margin of safety -64.0%
vs market (rating basis) -37.4%

A post-divestiture flavor house where value depends on margins catching up with Givaudan, not on growth.

The story

IFF is a scale player in flavors, fragrances, food ingredients and biosciences. Its moat comes from formulation know-how, regulatory files and customer co-development that make it sticky inside the products of consumer staples companies. After the debt-funded N&B merger destroyed value, the company is now in a repair and portfolio-pruning phase: Pharma Solutions has been sold, debt is coming down, and the remaining business is a mature, low-single-digit grower. Its value depends on rebuilding margins toward peer levels, not on growth.

The fall in TTM revenue from 10.9B to 9.2B comes from the Pharma Solutions divestiture, not from organic decline, so I keep 3.5% growth off the smaller base. I raise sales-to-capital from 0.9 to 1.6, a 78% increase, because the reported 0.46 is inflated by merger goodwill: capex now runs below D&A, so incremental capital needs are modest. Last time's value was 70% below the market, which signaled this driver was too punitive. I lift target margin slightly, from 15.5% to 16.5%, because amortization of acquired intangibles rolls off and the divestiture leaves a higher-margin mix, which puts IFF between Symrise and Givaudan.

Value drivers

Revenue growth (Y1)3.5%
Terminal growth3.0%
Forecast horizon7y
Target operating margin16.5%
Years to target margin5
Sales-to-capital1.60
Beta1.00
Failure probability2.0%
Cost of capital (WACC)9.4%
Terminal WACC9.4%

Valuation bridge

PV of explicit FCFF4.05B
PV of terminal value8.75B
Equity value7.22B
÷ shares → per share$28.82

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 9.55B 3.5% 6.3% 475.27M 201.82M 273.45M 249.89M
2 9.88B 3.4% 8.9% 690.43M 203.91M 486.53M 406.30M
3 10.20B 3.3% 11.4% 919.01M 205.73M 713.28M 544.34M
4 10.54B 3.2% 14.0% 1.16B 207.28M 953.85M 665.20M
5 10.87B 3.2% 16.5% 1.42B 208.52M 1.21B 770.07M
6 11.20B 3.1% 16.5% 1.46B 209.47M 1.25B 728.62M
7 11.54B 3.0% 16.5% 1.50B 210.09M 1.29B 688.83M

Key risks

  • Margin repair stalls as volume weakness at consumer staples customers and destocking persist
  • Further goodwill impairments or poorly priced divestitures (for example in Food Ingredients) destroy more capital
  • Leverage of about 5.4B net debt limits flexibility if EBITDA disappoints

Catalysts

  • Further portfolio pruning that cuts debt and leaves a higher-margin taste and scent core
  • GAAP operating margin moving visibly toward mid-teens as amortization declines and productivity programs deliver

History

DatePriceIntrinsicMoSRating
2026-11-17$79.99 $28.82 -64.0% SELL
2026-10-16$90.29 $26.57 -70.6% SELL
2026-09-15$83.43 $0.00 -100.0% STRONG SELL
2026-08-13$83.85 $0.00 -100.0% STRONG SELL
2026-07-09$78.94 $23.85 -69.8% SELL
2026-06-23$74.71 $24.08 -67.8% SELL